COSTAMARE INC (CMRE)

MHY1771G1026 - Common Stock

12.48  +0.12 (+0.97%)

After market: 12.48 0 (0%)

Fundamental Rating

5

CMRE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 29 industry peers in the Marine Transportation industry. CMRE has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on CMRE.



5

1. Profitability

1.1 Basic Checks

CMRE had positive earnings in the past year.
CMRE had a positive operating cash flow in the past year.
Of the past 5 years CMRE 4 years were profitable.
CMRE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CMRE's Return On Assets of 6.71% is fine compared to the rest of the industry. CMRE outperforms 68.97% of its industry peers.
With a decent Return On Equity value of 14.88%, CMRE is doing good in the industry, outperforming 72.41% of the companies in the same industry.
CMRE has a Return On Invested Capital of 6.08%. This is comparable to the rest of the industry: CMRE outperforms 58.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CMRE is in line with the industry average of 7.90%.
Industry RankSector Rank
ROA 6.71%
ROE 14.88%
ROIC 6.08%
ROA(3y)8.86%
ROA(5y)5.62%
ROE(3y)20.85%
ROE(5y)13.15%
ROIC(3y)7.75%
ROIC(5y)6.8%

1.3 Margins

CMRE has a Profit Margin of 23.47%. This is in the better half of the industry: CMRE outperforms 62.07% of its industry peers.
CMRE's Profit Margin has improved in the last couple of years.
CMRE has a Operating Margin (23.55%) which is in line with its industry peers.
CMRE's Operating Margin has declined in the last couple of years.
CMRE has a Gross Margin (41.18%) which is in line with its industry peers.
CMRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.55%
PM (TTM) 23.47%
GM 41.18%
OM growth 3Y-15.39%
OM growth 5Y-5.76%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-16.82%
GM growth 5Y-9.69%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMRE is creating some value.
CMRE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CMRE has more shares outstanding
The debt/assets ratio for CMRE has been reduced compared to a year ago.

2.2 Solvency

CMRE has an Altman-Z score of 1.19. This is a bad value and indicates that CMRE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.19, CMRE is in line with its industry, outperforming 48.28% of the companies in the same industry.
CMRE has a debt to FCF ratio of 9.57. This is a negative value and a sign of low solvency as CMRE would need 9.57 years to pay back of all of its debts.
CMRE has a better Debt to FCF ratio (9.57) than 62.07% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that CMRE is somewhat dependend on debt financing.
CMRE has a Debt to Equity ratio of 0.85. This is in the lower half of the industry: CMRE underperforms 75.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 9.57
Altman-Z 1.19
ROIC/WACC0.94
WACC6.5%

2.3 Liquidity

A Current Ratio of 1.69 indicates that CMRE should not have too much problems paying its short term obligations.
CMRE has a Current ratio (1.69) which is in line with its industry peers.
CMRE has a Quick Ratio of 1.59. This is a normal value and indicates that CMRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.59, CMRE perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.59

4

3. Growth

3.1 Past

The earnings per share for CMRE have decreased strongly by -36.59% in the last year.
Measured over the past years, CMRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 37.06% on average per year.
Looking at the last year, CMRE shows a very strong growth in Revenue. The Revenue has grown by 35.70%.
CMRE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.77% yearly.
EPS 1Y (TTM)-36.59%
EPS 3Y26.81%
EPS 5Y37.06%
EPS growth Q2Q11.48%
Revenue 1Y (TTM)35.7%
Revenue growth 3Y48.63%
Revenue growth 5Y31.77%
Revenue growth Q2Q86.45%

3.2 Future

The Earnings Per Share is expected to decrease by -0.97% on average over the next years.
Based on estimates for the next years, CMRE will show a decrease in Revenue. The Revenue will decrease by -7.57% on average per year.
EPS Next Y34.86%
EPS Next 2Y-0.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.58%
Revenue Next 2Y-7.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.00, the valuation of CMRE can be described as very cheap.
Based on the Price/Earnings ratio, CMRE is valued a bit cheaper than 75.86% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.28. CMRE is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 4.45, the valuation of CMRE can be described as very cheap.
Based on the Price/Forward Earnings ratio, CMRE is valued a bit cheaper than the industry average as 79.31% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CMRE to the average of the S&P500 Index (20.88), we can say CMRE is valued rather cheaply.
Industry RankSector Rank
PE 6
Fwd PE 4.45

4.2 Price Multiples

65.52% of the companies in the same industry are more expensive than CMRE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CMRE is valued a bit cheaper than the industry average as 75.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.98
EV/EBITDA 5.67

4.3 Compensation for Growth

CMRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.17
PEG (5Y)0.16
EPS Next 2Y-0.97%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CMRE has a Yearly Dividend Yield of 3.75%. Purely for dividend investing, there may be better candidates out there.
CMRE's Dividend Yield is a higher than the industry average which is at 4.76.
CMRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.75%

5.2 History

The dividend of CMRE has a limited annual growth rate of 5.41%.
CMRE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)5.41%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

20.26% of the earnings are spent on dividend by CMRE. This is a low number and sustainable payout ratio.
DP20.26%
EPS Next 2Y-0.97%
EPS Next 3YN/A

COSTAMARE INC

NYSE:CMRE (5/3/2024, 7:04:00 PM)

After market: 12.48 0 (0%)

12.48

+0.12 (+0.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.48B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.75%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6
Fwd PE 4.45
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.17
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 6.71%
ROE 14.88%
ROCE
ROIC
ROICexc
ROICexgc
OM 23.55%
PM (TTM) 23.47%
GM 41.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.69
Quick Ratio 1.59
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-36.59%
EPS 3Y26.81%
EPS 5Y
EPS growth Q2Q
EPS Next Y34.86%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)35.7%
Revenue growth 3Y48.63%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y